Finally, the involvement of the pro-survival PI3K/AKT and JAK/STAT pathways in NB has also been disclosed in a variety of studies, sometimes acting in coordination with MAPK activities; the inhibition of the effectors of these pathways as a NB therapeutic option is under scrutiny [44,87,88,89,90]. The gene discussed is AKT1; the disease is neuroblastoma.